As of June 13, 2025, Albireo Pharma Inc (ALBO) reports a Graham Number of 18.79.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Albireo Pharma Inc's Graham Number to Peers
To better understand Albireo Pharma Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Albireo Pharma Inc (ALBO) | 18.79 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Akouos Inc (AKUS) | 19.49 |
Compared to its competitors, Albireo Pharma Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.